About Anzics

The Australian and New Zealand Intensive Care Society is the leading advocate on all intensive care related matters. ANZICS leads the world in intensive care research through its Clinical Trials Group and patient databases, including the Adult Patient Database, the Paediatric Intensive Care Registry and Critical Care Resources. The Society is devoted to all aspects of intensive care medical practice through ongoing profes​sional education, the provision of leadership in medical settings, clinical research and analysis of critical care resources.

About Anzics
Not an ANZICS Member?
Become an ANZICS member today for a great range of benefits.

This message is only visible to admins.

Problem displaying Facebook posts.
Click to show error

Error: The access token could not be decrypted
Type: OAuthException

This message is only visible to admins.

Problem displaying Facebook posts.
Click to show error

Error: The access token could not be decrypted
Type: OAuthException

REGISTRATIONS NOW OPEN & PROGRAM AVAILABLE!
Head to: http://shorturl.at/fuyHQ for more information!

Confirming stellar international faculty line up for next ANZICS/ACCCN ASM 2020, Sydney. Look forward to releasing a quality scientific programme in next few weeks.. Save the date and Stay tuned.. #asm20Sydney

Often on #medtwitter #NurseTwitter we see call outs of the bad kind. I’m here to do the opposite and commend @anzics @ACCCNAUST on the cultural and gender diversity of invited speakers at the upcoming @ANZICSACCCN_ASM

Well done!

http://intensivecareasm.com.au

A reminder to Save the Date for #ASM20Sydney We are excited to begin profiling the International Speakers and program in the coming weeks!

This daily infographic provides a quick view of the current coronavirus (#COVID19) situation in Australia. https://www.health.gov.au/news/health-alerts/novel-coronavirus-2019-ncov-health-alert/coronavirus-covid-19-current-situation-and-case-numbers

Victoria’s response to a resurgence of #COVID19 has averted 9000-37000 cases in July 2020 ... #preprint #openaccess ... "control measures have reduced the reproduction ratio from 1.75 to 1.16 & averted 9000–37000 infections in July" https://www.mja.com.au/journal/2020/victorias-response-resurgence-covid-19-has-averted-9000-37000-cases-july-2020 #medtwitter

Victoria’s response to a resurgence of COVID-19 has averted 9,000-37,000 cases in July 2020 | The Medical Journal of Australia ⁦@theMJA⁩ https://www.mja.com.au/journal/2020/victorias-response-resurgence-covid-19-has-averted-9000-37000-cases-july-2020

UPDATE: Guideline recs this week include:
• Dexamethasone for pregnant or breastfeeding women
• Prone positioning for pregnant & postpartum women
• ECMO for pregnant & postpartum women
http://covid19evidence.net.au
@anzics @ranzcog @ACCCNAUST @ACM @tsanz_thoracic @TheRACP @ASID

Thank you to all the Nitric on By-pass families for participating in this world leading work @PCCRG_Research @HeartKidsAust @ https://twitter.com/PCCRG_Research/status/1262656780812705792

Happy International Clinical Trials Day @PCCRG_Research @anzics @HeartKidsAust

On Clinical Trials Day #CTD2020 we would like to gratefully acknowledge the support of our funders, collaborators, site staff, and participants who make trials like REMAP-CAP possible. https://twitter.com/nhmrc/status/1262890244824801281

We’re marking Clinical Trials Day, #CTD2020, by releasing a short story about @REMAP_CAP. Over 180 ICUs in 14 countries are trialling more than 20 pneumonia treatments to save the lives of critically ill COVID-19 patients. http://bit.ly/3e2IRQJ. http://remapcap.org